Succession Plan for the Federal Mediation and Conciliation Service, 97617-97618 [2024-28847]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 236 / Monday, December 9, 2024 / Notices
97617
CALENDAR OF REPORTING DATES FOR FLORIDA SPECIAL ELECTIONS—Continued
Close of books 1
Report
Reg./Cert. &
overnight
mailing deadline
Filing deadline
If Two Elections Are Held, PACs and Party Committees Not Filing Monthly Involved in Only the Special General (04/01/2025) Must File:
Pre-General ...............................................................................................................
Post-General ..............................................................................................................
Mid-Year ....................................................................................................................
03/12/2025
04/21/2025
06/30/2025
03/17/2025
05/01/2025
07/31/2025
03/20/2025
05/01/2025
07/31/2025
If One Election Is Held, Candidate Committees Involved in the Special General (01/28/2025) Must File:
Pre-General & Year-End 3 .........................................................................................
Post-General ..............................................................................................................
April Quarterly ............................................................................................................
01/08/2025
02/17/2025
03/31/2025
01/13/2025
02/27/2025
04/15/2025
01/16/2025
02/27/2025
04/15/2025
If One Election Is Held, PACs and Party Committees Not Filing Monthly Involved in the Special General (01/28/2025) Must File:
Pre-General & Year-End 3 .........................................................................................
Post-General ..............................................................................................................
Mid-Year ....................................................................................................................
01/08/2025
02/17/2025
06/30/2025
01/13/2025
02/27/2025
07/31/2025
01/16/2025
02/27/2025
07/31/2025
1 The reporting period always begins the day after the closing date of the last report filed. If the committee is new and has not previously filed
a report, the first report must cover all activity that occurred before the committee registered as a political committee up through the close of
books for the first report due.
2 Committees should file a consolidated Pre-Primary & Year-End Report by the filing deadline of the Pre-Primary Report.
3 Committees should file a consolidated Pre-General & Year-End Report by the filing deadline of the Pre-General Report (if primary not held).
Dated: December 3, 2024.
On behalf of the Commission.
Sean J. Cooksey,
Chairman, Federal Election Commission.
Proposed Revisions to Directives 10
(Rules of Procedure of the Federal
Election Commission Pursuant to 2
U.S.C. 437(c)(e)) and 17 (Circulation
Authority; Agenda Deadline
Procedures)
Election of Officers for 2025
Management and Administrative
Matters
[FR Doc. 2024–28771 Filed 12–6–24; 8:45 am]
BILLING CODE 6715–01–P
FEDERAL ELECTION COMMISSION
CONTACT PERSON FOR MORE INFORMATION:
Sunshine Act Meetings
Thursday, December 12,
2024, 10:00 a.m.
PLACE: Hybrid meeting: 1050 First Street
NE, Washington, DC (12TH Floor) and
virtual.
TIME AND DATE:
Note: If you would like to virtually access
the meeting, see the instructions below.
This meeting will be open to the
public. To access the meeting virtually,
go to the Commission’s website
www.fec.gov and click on the banner to
be taken to the meeting page.
MATTERS TO BE CONSIDERED:
Draft Advisory Opinion 2024–15:
Unified Libertarians of Massachusetts
MUR 1604 (Brady Campaign to Prevent
Gun Violence, et al):
Recommendation to Relieve the Brady
Campaign from a Remedial Measure
in a Conciliation Agreement
REG 2024–06 (Request to Modify or
Redact Contributor Info)—Draft
Notice of Proposed Rulemaking
Draft Legislative Recommendations
2024
Sample LLC Donor Form
Recommendation That the Office of
General Counsel Conduct a Review of
the Agency’s Regulations
ddrumheller on DSK120RN23PROD with NOTICES1
STATUS:
VerDate Sep<11>2014
16:08 Dec 06, 2024
Jkt 265001
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
Individuals who plan to attend in
person and who require special
assistance, such as sign language
interpretation or other reasonable
accommodations, should contact Laura
E. Sinram, Secretary and Clerk, at (202)
694–1040 or secretary@fec.gov, at least
72 hours prior to the meeting date.
(Authority: Government in the Sunshine Act,
5 U.S.C. 552b)
Laura E. Sinram,
Secretary and Clerk of the Commission.
[FR Doc. 2024–28995 Filed 12–5–24; 4:15 pm]
BILLING CODE 6715–01–P
this notice to inform the public of the
succession plan for the Federal
Mediation and Conciliation Service
(FMCS) provided by the Director of
FMCS. This notice supersedes all prior
succession plans issued by the agency
for officials performing the functions
and duties of the Director of FMCS.
DATES: This succession plan for the
FMCS is effective December 9, 2024.
FOR FURTHER INFORMATION CONTACT: For
specific questions related to this notice,
please contact Greg Goldstein, 202–606–
8111, ggoldstein@fmcs.gov.
SUPPLEMENTARY INFORMATION: By the
authority vested in the Director of the
Federal Mediation and Conciliation
Service (FMCS) by 29 U.S.C. 172, and to
provide for the continuity of essential
operations of the FMCS in all
circumstances this Notice provides the
succession plan of officials authorized
to perform the functions and duties of
the Director of the Federal Mediation
and Conciliation Service. The following
is the succession plan of officials hereby
ordered:
Order of Succession
FEDERAL MEDIATION AND
CONCILIATION SERVICE
Succession Plan for the Federal
Mediation and Conciliation Service
Federal Mediation and
Conciliation Service (FMCS).
ACTION: Notice of succession plan for the
FMCS.
AGENCY:
The Federal Mediation and
Conciliation Service (FMCS) is issuing
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
During any period in which the
Director has died, resigned, or otherwise
become unable to perform the functions
and duties of the office of the Director,
and there is no Acting Director serving
under the Federal Vacancies Reform Act
of 1998, 5 U.S.C. 3345–3349d, the
following officers of the FMCS, in the
order listed, are hereby delegated the
authority to perform the functions and
duties of the Director, to the extent
permitted by law:
E:\FR\FM\09DEN1.SGM
09DEN1
97618
Federal Register / Vol. 89, No. 236 / Monday, December 9, 2024 / Notices
1. Principal Deputy, Chief Operating
Officer;
2. Deputy Director, Field Operations;
3. Deputy Director for Labor Policy
and Communications;
4. Director, Procurement and
Operational Support;
5. General Counsel;
6. Associate Deputy Director for Field
Operations, National;
7. Associate Deputy Director for Field
Operations, Regional;
8. Director, Human Resources; and
9. Director, Budget.
No individual who is serving in an
office listed in this order in an acting
capacity, by virtue of so serving, shall be
delegated the functions and duties of
the Director.
Dated: December 4, 2024.
Gregory Goldstein,
Chief Operating Officer Performing the Duties
of the Director.
[FR Doc. 2024–28847 Filed 12–6–24; 8:45 am]
BILLING CODE 6732–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Medical Care for Adults
With Down Syndrome
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submission.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review on
Medical Care for Adults with Down
Syndrome, which is currently being
conducted by the AHRQ’s Evidencebased Practice Centers (EPC) Program.
Access to published and unpublished
pertinent scientific information will
improve the quality of this review.
DATES: Submission Deadline on or
before January 8, 2025.
ADDRESSES:
Email submissions: epc@
ahrq.hhs.gov.
Print submissions:
Mailing Address: Center for Evidence
and Practice Improvement, Agency for
Healthcare Research and Quality,
ATTN: EPC SEADs Coordinator, 5600
Fishers Lane Mail Stop 06E53A,
Rockville, MD 20857
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:08 Dec 06, 2024
Jkt 265001
Shipping Address (FedEx, UPS, etc.):
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers Lane,
Mail Stop 06E77D, Rockville, MD
20857.
FOR FURTHER INFORMATION CONTACT:
Kelly Carper, telephone: 301–427–1656
or email: epc@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Medical Care for Adults
with Down Syndrome. AHRQ is
conducting this review pursuant to
section 902 of the Public Health Service
Act, 42 U.S.C. 299a.
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Medical Care for Adults
with Down Syndrome. The entire
research protocol is available online at:
https://effectivehealthcare.ahrq.gov/
products/care-adults-down-syndrome/
protocol.
This is to notify the public that the
EPC Program would find the following
information on Medical Care for Adults
with Down Syndrome helpful:
D A list of completed studies that
your organization has sponsored for this
topic. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov, a
summary, including the following
elements, if relevant: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
D A list of ongoing studies that your
organization has sponsored for this
topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including, if relevant, a study
number, the study period, design,
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
methodology, indication and diagnosis,
proper use instructions, inclusion and
exclusion criteria, and primary and
secondary outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this topic and an index
outlining the relevant information in
each submitted file.
Your contribution is very beneficial to
the Program. Materials submitted must
be publicly available or able to be made
public. Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on topics not included in
the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program website and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://effectivehealthcare.ahrq.gov/
email-updates.
The review will answer the following
questions. This information is provided
as background. AHRQ is not requesting
that the public provide answers to these
questions.
Key Questions (KQ)
1. What are the benefits, harms, and
considerations of screening and
diagnostic interventions, for cooccurring medical and behavioral health
conditions in adults with Down
syndrome?
2. What are the benefits and harms,
and considerations of interventions to
treat co-occurring medical and
behavioral health conditions
specifically in adults with Down
syndrome?
Contextual Questions (CQ)
1. What conditions occur at an
increased or decreased prevalence in
adults with Down syndrome compared
to the general adult population. How
does prevalence vary by age/decade of
age, gender, setting (rural), and race/
ethnicity?
2. How do clinical symptoms and the
presentation of common co-occurring
behavioral/mental health conditions
(e.g., anxiety and depression) differ
among adults with Down syndrome
compared to their presentation in the
general adult population?
E:\FR\FM\09DEN1.SGM
09DEN1
]]>Agencies
[Federal Register Volume 89, Number 236 (Monday, December 9, 2024)]
[Notices]
[Pages 97617-97618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28847]
=======================================================================
-----------------------------------------------------------------------
FEDERAL MEDIATION AND CONCILIATION SERVICE
Succession Plan for the Federal Mediation and Conciliation
Service
AGENCY: Federal Mediation and Conciliation Service (FMCS).
ACTION: Notice of succession plan for the FMCS.
-----------------------------------------------------------------------
SUMMARY: The Federal Mediation and Conciliation Service (FMCS) is
issuing this notice to inform the public of the succession plan for the
Federal Mediation and Conciliation Service (FMCS) provided by the
Director of FMCS. This notice supersedes all prior succession plans
issued by the agency for officials performing the functions and duties
of the Director of FMCS.
DATES: This succession plan for the FMCS is effective December 9, 2024.
FOR FURTHER INFORMATION CONTACT: For specific questions related to this
notice, please contact Greg Goldstein, 202-606-8111,
[email protected].
SUPPLEMENTARY INFORMATION: By the authority vested in the Director of
the Federal Mediation and Conciliation Service (FMCS) by 29 U.S.C. 172,
and to provide for the continuity of essential operations of the FMCS
in all circumstances this Notice provides the succession plan of
officials authorized to perform the functions and duties of the
Director of the Federal Mediation and Conciliation Service. The
following is the succession plan of officials hereby ordered:
Order of Succession
During any period in which the Director has died, resigned, or
otherwise become unable to perform the functions and duties of the
office of the Director, and there is no Acting Director serving under
the Federal Vacancies Reform Act of 1998, 5 U.S.C. 3345-3349d, the
following officers of the FMCS, in the order listed, are hereby
delegated the authority to perform the functions and duties of the
Director, to the extent permitted by law:
[[Page 97618]]
1. Principal Deputy, Chief Operating Officer;
2. Deputy Director, Field Operations;
3. Deputy Director for Labor Policy and Communications;
4. Director, Procurement and Operational Support;
5. General Counsel;
6. Associate Deputy Director for Field Operations, National;
7. Associate Deputy Director for Field Operations, Regional;
8. Director, Human Resources; and
9. Director, Budget.
No individual who is serving in an office listed in this order in
an acting capacity, by virtue of so serving, shall be delegated the
functions and duties of the Director.
Dated: December 4, 2024.
Gregory Goldstein,
Chief Operating Officer Performing the Duties of the Director.
[FR Doc. 2024-28847 Filed 12-6-24; 8:45 am]
BILLING CODE 6732-01-P
